Page last updated: 2024-08-24

adapalene and minocycline

adapalene has been researched along with minocycline in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (85.71)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Celi, E; Ng, CH; Schweitzer, I; Tam, MM; Tate, B1
Purdy, S1
DeWitt, CA; Siroy, AE; Stone, SP1
Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E1
Bikowski, J; Del Rosso, JQ1
Czilli, T; Knezevic, S; Peters, C; Tan, J1

Reviews

1 review(s) available for adapalene and minocycline

ArticleYear
Acne vulgaris.
    Clinical evidence, 2006, Issue:15

    Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Erythromycin; Humans; Isotretinoin; Minocycline; Naphthalenes; Tetracycline; Tretinoin; Zinc

2006

Trials

1 trial(s) available for adapalene and minocycline

ArticleYear
Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy.
    The Australasian journal of dermatology, 2002, Volume: 43, Issue:4

    Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Depression; Dermatologic Agents; Female; Humans; Isotretinoin; Male; Middle Aged; Minocycline; Naphthalenes; Quality of Life

2002

Other Studies

5 other study(ies) available for adapalene and minocycline

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:3

    Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Colonic Neoplasms; Dermatologic Agents; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Isotretinoin; Lung Neoplasms; Male; Middle Aged; Minocycline; Naphthalenes

2007
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
    Cutis, 2006, Volume: 78, Issue:2 Suppl 1

    Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin

2006
Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.
    Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:6

    Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Keratolytic Agents; Male; Microspheres; Minocycline; Naphthalenes; Tretinoin

2008
Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
    Journal of cutaneous medicine and surgery, 2016, Volume: 20, Issue:6

    Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Androstenes; Anti-Bacterial Agents; Benzoyl Peroxide; Canada; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Doxycycline; Drug Combinations; Estrogens; Ethinyl Estradiol; Humans; Isotretinoin; Mineralocorticoid Receptor Antagonists; Minocycline; Practice Guidelines as Topic; Severity of Illness Index; Tetracycline

2016